Designer compound may lead to new dementia treatment

View Content

Feb. 8 (UPI) — Research from the National Institutes of Health, or NIH, suggests the potential to prevent or reverse brain damage caused by tau protein in dementia patients.

The study of mice and monkeys showed that tau antisense oligonucleotides, which are genetically engineered to block a cell’s production of tau, have the potential to treat neurodegenerative disorders such as dementia.